Sun Pharmaceutical Industries Ltd. $SUNPHARMA.NS, India’s largest drugmaker, announced a significant reshuffle at the top level: Kirti Ganorkar, head of its domestic operations since 2019, will become Managing Director starting September 1. The move reflects a calculated succession strategy aimed at reinforcing leadership depth and operational resilience across its global network. Ganorkar’s elevation marks a pivotal shift from founder-centric management to institutional leadership, a transition increasingly common among large-cap Indian corporations navigating global expansion, regulatory complexities, and innovation pressure.